OACCW Stock - Oaktree Acquisition Corp. III Life Sciences
Unlock GoAI Insights for OACCW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 |
|---|---|
| Revenue | N/A |
| Gross Profit | N/A |
| Gross Margin | N/A |
| Operating Income | $-351,806 |
| Net Income | $1.33M |
| Net Margin | N/A |
| EPS | $0.05 |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Visit WebsiteEarnings History & Surprises
OACCWLatest News
Frequently Asked Questions about OACCW
What is OACCW's current stock price?
What is the analyst price target for OACCW?
What sector is Oaktree Acquisition Corp. III Life Sciences in?
What is OACCW's market cap?
Does OACCW pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to OACCW for comparison